|
0001104659 11 012985 txt
|
| Item 7.01 (Regulation FD Disclosure) ; Attachment I contains presentation materials for IBM’s Investor Briefing on March 8, 2011. Attachment II (Non-GAAP Supplementary Materials) contains supplementary materials about non-GAAP financial measures in certain presentation materials for this event. IBM’s web site (www.ibm.com) contains a significant amount of information about IBM, including financial and other information for investors (www.ibm.com/investor/). IBM encourages investors to visit its various web sites from time to time, as inform ... |
|
|
0001104659 19 000498 txt
|
| Item 7.01 Regulation FD Disclosure. On January 3, 2019, BioXcel Therapeutics, Inc. (the “Company”) held an investor conference call and discussed the results of the study described in Item 8.01 below and the Company’s BXCL501 program. In connection with the investor call, the Company prepared presentation materials (“the Presentation Materials”), a copy of which are furnished as Exhibit 99.1 to this current report on Form 8-K. The call will be available via a live, listen-only webcast at http://public.viavid.com/index.php?id=132677 an ... |
|
|
0001104659-20-123759.txt
|
| Booz Allen Hamilton Holding Corporation ; Lloyd W. Howell, Jr. ; Executive Vice President, Chief Financial Officer and Treasurer |
|
|
0001104659 18 052534 txt
|
| Items 2.02 · and 8.01 Results of Operations and Financial Condition and Other Events. The following consists of Deere & Company’s press release dated August 17, 2018 concerning Third Quarter of Fiscal 2018 financial results and supplemental financial information filed as Exhibit 99.1 to this report and incorporated by reference herein. Item 9.01 Financial Statements and Exhibits. (d) Exhibits · (99.1) Press release and supplemental financial information (Filed herewith) · Items 2.02 ... |
|
|
0001104659-14-038524.txt
|
| Item 7.01 (Regulation FD Disclosure) ; Attachment I contains presentation materials for the afternoon session of IBM’s Investor Briefing on May 14, 2014. See Attachment II (non-GAAP supplemental materials) in the Form 8-K dated May 14, 2014 filed earlier today, which contains supplemental materials about non-GAAP financial measures in certain presentation materials for the morning and afternoon sessions of this event. IBM’s web site (www.ibm.com) contains a significant amount of information about IBM, including financial and other informati ... |
|
|
0001104659-18-015787.txt
|
| Item 7.01 (Regulation FD Disclosure) ; Exhibit 99.1 contains IBM’s presentation materials for IBM’s Investor Briefing on March 8, 2018. The information in this Item 7.01, including the corresponding Exhibit 99.1, is being furnished with the Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”). In an effort to provide investors with additional information regarding the company’s results as determined by generally accepted accounting principles (GAAP), the ... |
|
|
0001104659-20-087652.txt
|
| a significant data breach or other disruption to our technology infrastructure; our ability... 9% Weighted Average Life (years) (2) 8.8 Regular Distribution Dates February 20 and August 20... |
|
|
Document
|
| 14d-2(b) under the Exchange Act o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act Item 5.... and a member of its Management Committee, State Street’s... |
|
|
https://www.sec.gov/Archives/edgar/data/51143/000110465916100072/0001104659-16-100072.txt
|
| Item 7.01 (Regulation FD Disclosure) ; Attachment I contains IBM’s Chief Financial Officer Martin Schroeter’s presentation materials for IBM’s Investor Briefing on February 25, 2016, which includes supplementary materials about non-GAAP financial measures in the presentation. Attachment II contains additional information about this presentation that has been posted on IBM’s Investor Relations website (www.ibm.com/investor/). Attachments I and II are hereby filed. These materials may contain forward-looking statements under the Private S ... |
|
|
0001104659-17-014730.txt
|
| Item 7.01 Regulation FD Disclosure. Exhibit 99.1 contains IBM’s presentation materials for the morning session of IBM’s Investor Briefing on March 7, 2017. The information in this Item 7.01, including the corresponding Exhibit 99.1, is being furnished with the Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”). These materials may contain forward-looking statements under the Private Securities Litigation Reform Act of 1995, which statements involve numero ... |
|
|
메인 > 네이버 검색결과
